This is a test
- 611 pages
- English
- PDF
- Available on iOS & Android
eBook - PDF
Controversial Statistical Issues in Clinical Trials
Book details
Table of contents
Citations
About This Book
In clinical trial practice, controversial statistical issues inevitably occur regardless of the compliance with good statistical practice and good clinical practice. But by identifying the causes of the issues and correcting them, the study objectives of clinical trials can be better achieved. Controversial Statistical Issues in Clinical Trials cov
Frequently asked questions
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Both plans give you full access to the library and all of Perlegoâs features. The only differences are the price and subscription period: With the annual plan youâll save around 30% compared to 12 months on the monthly plan.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, weâve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes, you can access Controversial Statistical Issues in Clinical Trials by Shein-Chung Chow in PDF and/or ePUB format, as well as other popular books in Medicine & Alternative & Complementary Medicine. We have over one million books available in our catalogue for you to explore.
Information
Table of contents
- Front Cover
- Contents
- Preface
- Chapter 1: Introduction
- Chapter 2: Good Statistical Practices
- Chapter 3: Bench-to-Bedside Translational Research
- Chapter 4: Bioavailability and Bioequivalence
- Chapter 5: Hypotheses for Clinical Evaluation and Significant Digits
- Chapter 6: Instability of Sample Size Calculation
- Chapter 7: Integrity of Randomization/Blinding
- Chapter 8: Clinical Strategy for Endpoint Selection
- Chapter 9: Protocol Amendments
- Chapter 10: Seamless Adaptive Trial Designs
- Chapter 11: Multiplicity in Clinical Trials
- Chapter 12: Independence of Data Monitoring Committee
- Chapter 13: Two-Way ANOVA versus One-Way ANOVA with Repeated Measures
- Chapter 14: Validation of QOL Instruments
- Chapter 15: Missing Data Imputation
- Chapter 16: Center Grouping
- Chapter 17: Non-Inferiority Margin
- Chapter 18: QT Studies with Recording Replicates
- Chapter 19: Multiregional Clinical Trials
- Chapter 20: Dose Escalation Trials
- Chapter 21: Enrichment Process in Target Clinical Trials
- Chapter 22: Clinical Trial Simulation
- Chapter 23: Traditional Chinese Medicine
- Chapter 24: The Assessment of Follow-On Biologic Products
- Chapter 25: Generalizability/Reproducibility Probability
- Chapter 26: Good Review Practices
- Chapter 27: Probability of Success
- References
- Back Cover